North East and North Cumbria
ICS Formulary
Home
About
Admin
netFormulary
Chapters
Medicines A-Z
News
Mobile
Reports
Feedback
Search
Recent Updates - Updated items
All Formulary Amendments
Records 1 to 20 of 20
Details
LDL
Link Added : NHSE Clinical Commissioning Policy: Obinutuzumab elective therapy to prevent immune Thrombotic Thrombocytopenic Purpura (TTP) relapse in patients who are refractory or intolerant to rituximab (adults) : https://www.england.nhs.uk/wp-content/
25/04/2024 11:09:32
(DavidS )
UPD
sitematrix Changed from 0 to
25/04/2024 11:07:54
(DavidS )
UPD
FurtherInformation Changed from
Approved for use in chronic lymphocytic leukaemia in combination with chlorambucil in patients who have co-morbitities that make full‑dose fludarabine‑based therapy unsuitable for them, only
25/04/2024 11:07:54
(DavidS )
UPD
Obinutuzumab SSC2579
25/04/2024 11:07:54
(DavidS )
LDL
Link Added : NICE TA629: Obinutuzumab with bendamustine for treating follicular lymphoma after rituximab : https://www.nice.org.uk/guidance/ta629
17/11/2022 14:20:19
(DavidS )
UPD
sitematrix Changed from 0 to
17/11/2022 14:19:58
(DavidS )
UPD
FurtherInformation Changed from
Approved for use in chronic lymphocytic leukaemia in combination with chlorambucil in patients who have co-morbitities that make full‑dose fludarabine‑based therapy unsuitable for them, only
17/11/2022 14:19:58
(DavidS )
UPD
Obinutuzumab NICE TA629
17/11/2022 14:19:58
(DavidS )
UPD
NHSE Changed from N
27/07/2022 08:32:25
(LoweryM )
UPD
sitematrix Changed from 0 to
27/07/2022 08:32:25
(LoweryM )
UPD
FurtherInformation Changed from
Approved for use in chronic lymphocytic leukaemia in combination with chlorambucil in patients who have co-morbitities that make full‑dose fludarabine‑based therapy unsuitable for them, only i
27/07/2022 08:32:25
(LoweryM )
UPD
Obinutuzumab NHSE
27/07/2022 08:32:25
(LoweryM )
UPD
Published from Draft Mode
27/10/2017 15:09:59
(DavidS )
LDL
Link Added : NICE TA472 Obinutuzumab with bendamustine for treating follicular lymphoma refractory to rituximab : https://www.nice.org.uk/guidance/ta472
26/10/2017 14:56:09
(DavidS )
UPD
Obinutuzumab NICE TA473
26/10/2017 14:55:45
(DavidS )
UPD
Obinutuzumab b
01/02/2017 15:51:52
(DavidS )
UPD
Obinutuzumab b
24/01/2017 13:15:07
(WhitehallJ )
UPD
Obinutuzumab (Gazyvaro
®
) b
24/01/2017 13:14:08
(WhitehallJ )
UPD
Obinutuzumab (Gazyvaro
®
) b
24/01/2017 13:13:42
(WhitehallJ )
UPD
Obinutuzumab (Gazyvaro
®
) build
28/11/2016 17:02:31
(DavidS )